Application Information

This drug has been submitted to the FDA under the reference 020569/001.

Names and composition

"VITRASERT" is the commercial name of a drug composed of GANCICLOVIR.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
020569/001 VITRASERT GANCICLOVIR IMPLANT/IMPLANTATION 4.5MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
020460/001 CYTOVENE GANCICLOVIR CAPSULE/ORAL 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
020460/002 CYTOVENE GANCICLOVIR CAPSULE/ORAL 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
020569/001 VITRASERT GANCICLOVIR IMPLANT/IMPLANTATION 4.5MG
022211/001 ZIRGAN GANCICLOVIR GEL/OPHTHALMIC 0.15%
076457/001 GANCICLOVIR GANCICLOVIR CAPSULE/ORAL 250MG
076457/002 GANCICLOVIR GANCICLOVIR CAPSULE/ORAL 500MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved